-
Crowdsourcing Trial Protocol in Prostate Cancer Trial
Oncology Times | A clinical trial out of the Mount Sinai School of Medicine in New York crowd-sourced its protocol, getting input from 43 physicians and 33 patients.
Mar 20, 2014
-
In Personalized Cancer Care, GeneKey Goes Beyond the Foundations
Clinical Informatics News | As biomarker-based gene panels gain acceptance as standard tools in the oncologist’s toolbox, GeneKey is going deeper, into the whole exome and transcriptome of its patients’ cancers. Can this approach yield new results?
Mar 14, 2014
-
PhRMA Launches Campaign to Increase Diversity in Clinical Trials
Clinical Informatics News Brief | Yesterday, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the National Minority Quality Forum announced a national campaign to help increase diversity in clinical trials.
Mar 13, 2014
-
Great Expectations for the eTMF
Clinical Informatics News | The eTMF industry is starting to mature, and has evolved beyond the early adoption phase from several years ago, when discussions focused mostly on the transition from the paper trial master file to an electronic version. Now we want more.
Mar 12, 2014
-
Clinipace Worldwide Merges with Pan-Asian CRO
News Medical | Clinipace Worldwide and Choice Pharma have merged. Clinipace is a global CRO and Choice Pharma is a Pan-Asian CRO.
Mar 12, 2014
-
IPO to Fund Nanoparticle Clinical Trials
Boston Globe | Cerulean Pharma is launching a $75 million IPO to fund clinical trials of its nanoparticle cancer-fighting technology.
Mar 11, 2014
-
Halamka's Favorite Primer on Meaningful Use
GeekDoctor Blog | John Halamka posted a nice primer on Meaningful Use Stage 2 and Health Information Services Providers.
Mar 7, 2014
-
What are the Future Trends in Clinical Research
Life Science Leader | What are the best practices that clinical research desperately needs to implement? One consultant surveyed colleagues in biotech and pharma and identified several.
Mar 5, 2014
-
Up to 16% of Clinical Trials May Fall Outside of Federal Safety Regulations
Philly.com | A research letter published today found that 5% to 16% of clinical trials do not fall under federal regulations that oversee "human subjects protections".
Mar 5, 2014
